← Back to Search

Core Body Temperature Monitoring in Endurance Athletes' Heat Training (CORE Trial)

N/A
Recruiting
Led By Christopher T Minson, PhD
Research Sponsored by University of Oregon
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 30 minutes
Awards & highlights

CORE Trial Summary

This trial looks at if a device can accurately measure an athlete's core body temp in different settings.

Who is the study for?
This trial is for male and female endurance athletes who are highly trained or elite, do not smoke, can read and speak English, and have no cardiovascular issues. It's not for those on certain heart meds (except oral contraceptives), with a history of blood clots or heat illness, gastrointestinal diseases, past smokers, pregnant women, or those trying to conceive.Check my eligibility
What is being tested?
The study tests the CORE™ device which measures core body temperature in athletes during heat training. The goal is to see how well it works under different environmental conditions.See study design
What are the potential side effects?
Since this trial involves a non-invasive monitoring device rather than medication or invasive procedures, significant side effects are not anticipated.

CORE Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~30 minutes
This trial's timeline: 3 weeks for screening, Varies for treatment, and 30 minutes for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Ability to accurately estimate core body temperature

CORE Trial Design

2Treatment groups
Experimental Treatment
Group I: Hot/HumidExperimental Treatment1 Intervention
Core body temperature, skin temperature, heart rate, and heat perceptions will be collected from elite athletes while running or cycling for 45 minutes in the heat at high humidity (28 degrees Celsius with 80-100% relative humidity).
Group II: Hot/DryExperimental Treatment1 Intervention
Core body temperature, skin temperature, heart rate, and heat perceptions will be collected from elite athletes while running or cycling for 45 minutes in the heat at low humidity (38 degrees Celsius with 10-20% relative humidity).

Find a Location

Who is running the clinical trial?

University of OregonLead Sponsor
80 Previous Clinical Trials
46,866 Total Patients Enrolled
Christopher T Minson, PhDPrincipal InvestigatorUniversity of Oregon
1 Previous Clinical Trials
50 Total Patients Enrolled

Media Library

Hot/Dry Clinical Trial Eligibility Overview. Trial Name: NCT05692947 — N/A
Fever Research Study Groups: Hot/Dry, Hot/Humid
Fever Clinical Trial 2023: Hot/Dry Highlights & Side Effects. Trial Name: NCT05692947 — N/A
Hot/Dry 2023 Treatment Timeline for Medical Study. Trial Name: NCT05692947 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is enrollment open for this experiment currently?

"According to clinicaltrials.gov, this medical trial is still in its recruitment phase after being initially posted on September 19th 2022 and last updated January 19th 2023."

Answered by AI

Who meets the criteria to participate in this trial?

"This medical trial is targeting 40 individuals aged 18-59 that currently have a fever. To be eligible, patients must meet the following prerequisites: Be an experienced or world-class athlete, Refrain from smoking, Have fluency in English language and not possess any cardiovascular issues."

Answered by AI

Is this research trial open to individuals aged 45 and over?

"This clinical trial is only open to individuals between 18 and 59 years old. There are separate studies available for minors, as well as seniors aged 65 and up."

Answered by AI

How many participants are actively involved in this clinical trial?

"Confirmed. On clinicaltrials.gov, the information on this trial reveals that it is actively recruiting participants since being initially posted in September of 2022 and recently updated in January of 2023. 40 patients are required at a single site for the study to proceed."

Answered by AI
~12 spots leftby Dec 2024